TotalMarketCap

Damora Therapeutics

DMRANasdaq DenmarkHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.207 B

$19.55 -3.31%

Close of 7 Oct 2026

As of 7 Oct 2026, Damora Therapeutics (DMRA) has a market capitalization of $1.21B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$209.8M

Loss-making

Shares outstanding

61,735,519

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #135KardiganKARD$1.26B
  2. #136Oric PharmaceuticalsORIC$1.24B
  3. #137Damora TherapeuticsDMRA$1.21B
  4. #138MannkindMNKD$1.19B
  5. #139HarrowHROW$1.14B

What if Damora Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.8T

$466,335.02

Per share 23,853× higher

Bitcoin $1.67T

$27,054.89

Per share 1,384× higher

Nvidia $5.77T

$93,393.30

Per share 4,777× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Damora Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.